Serum VLDL Cholesterol is a test carried out at Molecular Diagnostics and Therapy, a high-quality diagnostic centre that is accredited by NABL and NABH. This is a blood test that measures the cholesterol carried in very-low-density lipoprotein (VLDL) particles in the blood. VLDL refers to a lipoprotein that transports triglycerides to various parts of the body. Lipid metabolism is assessed with a level test to see if the metabolism is normal or not, which relates to cardiovascular risk.
A blood test that determines the amount of cholesterol bound to very-low-density lipoproteins in the blood is called the VLDL Cholesterol test. Depending on the measurement technique, VLDL cholesterol can be estimated from the level of triglycerides, or can be measured using a special test. The results allow the findings of lipid metabolism to be obtained and help to identify the relationship between the triglycerides and the various types of cholesterol. VLDL is normally read in conjunction with the level of LDL, HDL, and total cholesterol, as well as triglycerides.
Dyslipidaemia means the blood contains abnormal levels of cholesterol and other fats, such as high LDL or triglycerides or low HDL (lipids). VLDL cholesterol test monitors the amount of one component of the lipid profile and abnormalities of lipids.
Hypertriglyceridaemia is an increase in the amount of triglycerides in the blood. The evaluation of VLDL cholesterol may supplement the evaluation, as VLDL particles contain a lot of triglycerides.
Plaque builds up in artery walls, narrowing the artery and making it stiffer, called atherosclerosis. VLDL and VLDL remnants might be involved in this process and be a factor in this increased cardiovascular risk.
A syndrome of four or more of the following conditions occurs: abdominal obesity, elevated blood pressure (hypertension), elevated blood fat levels (hyperlipidaemia), and elevated blood glucose levels (hyperglycaemia). This condition could be correlated with the varying levels of VLDL and triglycerides.
It is important to keep track of VLDL as well, as it can be abnormal and is considered in assessing cardiovascular risk, and VLDL is a contributor to atherosclerosis. The results of this measurement are interpreted in the context of other lipid measurements and health factors.
Molecular Diagnostics and Therapy is a new integrated discipline that combines Radiology, Nuclear Medicine, and Pathology, allowing for more efficient, integrated care and therapy of patients. In our laboratory, the following good practices are followed for the management of serum samples; the procedures for testing serum samples and QA procedures are adopted. We always have the ultimate focus of thorough and pertinent reporting, reliable diagnostic support, and quality patient-centred care processes, without which informed clinical decisions cannot be made.
To be tested at Molecular Diagnostics and Therapy, call the lab and follow any preparation instructions given to you by your doctor or the lab staff. Take your prescription and any previously prepared lipid profile reports (if any) to be evaluated and compared.
Test information: Fasting for 9–12 hours may be advised.
Reporting: Within 24 hours*